TheStreet home
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

LATEST NEWS

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)
STOCKS

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

Today's Weak On High Volume Stock: Spirit AeroSystems Holdings (SPR)
MARKETS

Insider Trading Alert - HEB, EPAY And STOR Traded By Insiders

3 Leisure Stocks Pushing Industry Growth
MARKETS

Insider Trading Alert - SKT, HEB And NURO Traded By Insiders

PTC Therapeutics (PTCT) Stock Upgraded at Jefferies
INVESTING

4 Biotech Stocks Under $10 to Trade for Breakouts

Regulators Greenlight Measure to Ban Fracking in Delaware River Basin
INVESTING

4 Stocks Under $10 Making Big Moves Higher

Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)
MARKETS

Insider Trading Alert - NDAQ, FEYE And HEB Traded By Insiders

3 Basic Materials Stocks Driving The Sector Higher
MARKETS

Insider Trading Alert - KCG, HEB And OXM Traded By Insiders

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: SBW, HIO, ETG
MARKETS

Insider Trading Alert - HEB, MS And IMPV Traded By Insiders

Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)
MARKETS

Insider Trading Alert - FTD, HEB And AWH Traded By Insiders

What to Expect From European Pharmaceuticals' First Quarter Results
STOCKS

Hemispherx Uses Ebola Tragedy to Raise Cash, Pay Executive Bonuses

Watch Out Amazon Mighty Walmart Could Fly in and Steal Whole Foods, JPMorgan Analyst Hints
OPINION

Regulators Want Drug Companies to Be Honest About FDA

Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

Biotech Stock Mailbag: Hep C stocks, Bluebird, Advaxis, Hemispherx

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS

U.S. Army Medical Researchers to Hemispherx: We're Really Not That Into You

Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point
STOCKS

Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx

Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Ebola Outbreak Puts the Spotlight on 10 Biotech Companies

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks

Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS

Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity

Ariad Pharmaceutical's Iclusig May Relieve Shareholders' Pain: StockTwits
INVESTING

Sarepta Should Shut Up About Ebola, Focus on Job No. 1

5 Stocks Poised for Breakouts
INVESTING

5 Stocks Poised for Breakouts

5 Hated Earnings Stocks You Should Love
INVESTING

3 Biotech Stocks Under $10 to Watch

Hedge Funds Love These 5 Consumer Stocks -- but Should You?
INVESTING

3 Health Care Stocks Under $10 to Watch

The 5 Dumbest Things on Wall Street This Week: May 3
OPINION

The 5 Dumbest Things on Wall Street This Week: May 3

5 Dumbest Things on Wall Street
VIDEO

5 Dumbest Things on Wall Street

Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

An Outrageous, Shameless Act by Hemispherx's Board of Directors

Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind
STOCKS

Sarepta Bear Speaks: Eteplirsen Accelerated Approval Will Be Denied